A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Recruiting · NCT07439653 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT07439653 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TORL Biotherapeutics, LLC | 8 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer and Blood Specialty Clinic, Los Alamitos | Los Alamitos | United States | 1 |
| Cancer Center of Kansas, Wichita | Wichita | United States | 1 |
| Providence Medical Foundation | Fullerton | United States | 46 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| Stanford University | Stanford | United States | 213 |
| UCLA | Santa Monica | United States | 14 |
| University of California Miami, Sylvester Comprehensive Cancer Center | Miami | United States | 1 |
| University of Iowa Health Care | Iowa City | United States | 47 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |